Mintz has been named a finalist for three awards by LSPN. The awards celebrate excellence across the industry, from trailblazing individuals to firms redefining the boundaries of life sciences IP.  

Mintz was named a finalist in the following firm and individual categories:  

• Life Sciences IP Firm of the Year
• Life Sciences IP Litigation Firm of the Year  
• Siegmund Gutman, Patent Litigator of the Year

The LSPN Awards are judged by an independent panel. Winners will be announced at the end of April at the LSPN North America Spring 2026 conference in Boston.  

Mintz’s Intellectual Property (IP) practice combines technical expertise with a deep understanding of the industry to deliver strategic solutions for life sciences companies. With over 130 IP professionals, including 40+ with PhDs in fields such as biology, biomedical engineering, cellular and molecular medicine, chemistry, and pharmacology, among others, the team offers comprehensive support in patent prosecution, litigation, and advisory services, including in emerging areas like cell-based therapies, life sciences AI, and machine learning.  

About Mintz

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto